Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05059236
Title A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. (ARASEC)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications

prostate adenocarcinoma

Therapies

Darolutamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.